(Total Views: 69)
Posted On: 12/09/2024 1:44:15 PM
Post# of 99243

$DYAI Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology https://finance.yahoo.com/news/dyadic-receive...00271.html

